SCHEMBL21786201

SCHEMBL21786201

CNC(C)=C1C(=O)CC(C)(C)CC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.46
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 4/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 2/20 0.41
MAOA P21397 1/20 0.38
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 2/20 0.34
GLA P06280 1/20 0.34
TDP2 O95551 1/20 0.33
SMAD3 P84022 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20059897 0.87 ALDH1A1 (0.43) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL21089427 0.78 POLB (0.41) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL8083467 0.77 ALDH1A1 (0.47) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL27182104 0.75 MEN1 (0.40) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL4198877 0.75 ALDH1A1 (0.38) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL13191817 0.75 ALDH1A1 (0.45) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL22328111 0.74 TDP1 (0.41) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL11611662 0.74 LMNA (0.38) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL7323969 0.73 ALDH1A1 (0.44) ALDH1A1TDP1MAPTPOLBKDM4E
SCHEMBL7323961 0.73 ALDH1A1 (0.48) ALDH1A1TDP1MAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010352-B1 A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES GYROS PROTEIN TECH AB (SE) 2023-10-18 EP disclosed
EP-4219446-A2 TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION Gyros Protein Technologies AB (SE) 2023-08-02 EP disclosed
WO-2023060858-A1 MONOCHROMATIC FLUORESCENCE MRT GENE SEQUENCING REAGENT AND METHOD BASED ON ENVIRONMENT-SENSITIVE DYE 深圳铭毅智造科技有限公司 2023-04-20 WO disclosed
US-20220211883-A1 FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO TRUSTEES OF TUFTS COLLEGE 2022-07-07 US disclosed
US-20210332082-A1 TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION Belyntic GmbH (DE) 2021-10-28 US disclosed
WO-2021023892-A1 A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES Belyntic GmbH (DE) 2021-02-11 WO disclosed
WO-2020043747-A1 TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION Belyntic GmbH (DE) 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332082-A1 TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION VIP, NGLY1, HM13 ALDH1A1 1635/4885TDP1 3829/4885MAPT 1722/4885
US-20220211883-A1 FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO FAP, FIBP, FGFR1 ALDH1A1 789/4885TDP1 283/4885MAPT 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.